The healthcare sector alone accounts for 10-15 percent of the GDP in most developed countries. And it is an industry in transition. Health tech, new genomics, social media and big data is transforming the industry, if not fundamentally, in the short or medium term, so at least significantly. What were mere visions a few years ago is now concrete reality.
Since 2007 we’ve been deeply involved in research on the future of health and healthcare. By then we started the Opinion Health foresight program with the ambition to unfold the future of health and healthcare in the light of technological progress and changing consumer values. The program has functioned as an unbiased arena for stakeholders across the industry to meet and discuss the future of the industry. Public and private healthcare providers, government representatives and patient organizations have been able to explore and envision the future together with senior representatives from pharmaceutical companies, insurance industry, ICT suppliers and other industries.
In the next 10 years, data science and software will do more for medicine than all of the biological sciences together. Vinod Khosla, Founder of Khosla Ventures
As a starting-point for Opinion Health as well as client specific strategy projects, we’ve accumulated a considerable amount of original research-based insights. We’ve interviewed thousands of health consumers, organized expert roundtables, conducted large-scale surveys among medical students, doctors, employers and healthcare stakeholders, researched the technology front, and scanned healthcare trends across the globe and much, much more.
The question is: Are you prepared for the technical, human and financial challenges and opportunities ahead?
Did you know that you could buy a genetic screening online for less that 200 USD?